HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Isabel W T Chu Selected Research

Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)

8/2013High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Isabel W T Chu Research Topics

Disease

2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2013 - 12/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2014
1Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase)
08/2013
1Neoplasms (Cancer)
06/2013
1Hematologic Neoplasms (Hematological Malignancy)
06/2013

Drug/Important Bio-Agent (IBA)

2Messenger RNA (mRNA)IBA
05/2014 - 06/2013
2imatinib (Gleevec)FDA Link
08/2013 - 12/2010
1Cytarabine (Cytosar-U)FDA LinkGeneric
08/2013
1Mercaptoethanol (2 Mercaptoethanol)IBA
06/2013
1RNA (Ribonucleic Acid)IBA
06/2013